Literature DB >> 16280205

Sow performance in an endemically porcine reproductive and respiratory syndrome (PRRS)-infected farm after sow vaccination with an attenuated PRRS vaccine.

C Alexopoulos1, S K Kritas, C S Kyriakis, E Tzika, S C Kyriakis.   

Abstract

The objective of this field study was to evaluate in an endemically porcine reproductive and respiratory syndrome (PRRS) virus-infected farm the reproductive performance of sows after their vaccination with a PRRS attenuated vaccine. In a farrow-to-finish pig farm with history of endemic PRRS virus infection, a total of 200 gilts and sows were used. They were divided in 2 groups of 100 animals. The first group was used as untreated controls, while the animals of the second group were vaccinated against PRRS virus using the attenuated Porcilis PRRS vaccine (Intervet International, The Netherlands) based on European strain. All health and reproductive parameters were recorded from the time of vaccination up to next weaning. No adverse systemic or local reactions or side effects relative to vaccination were noted. Compared to controls, vaccinated sows showed significantly improved farrowing rate (89% versus 78%) and a tendency for fewer returns to oestrus, particularly those at irregular intervals. Fewer sows farrowed prematurely and showed post-partum dysgalactia syndrome, but more live pigs were born and weaned in each litter after vaccination. It was concluded that vaccination of sows with Porcilis PRRS attenuated vaccine in farms with endemic PRRSV infection has beneficial effects on their health and fertility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280205     DOI: 10.1016/j.vetmic.2005.10.007

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  14 in total

1.  Seroprevalence of porcine reproductive and respiratory syndrome, Aujeszky's disease, and porcine parvovirus in replacement gilts in Thailand.

Authors:  Padet Tummaruk; Rachod Tantilertcharoen
Journal:  Trop Anim Health Prod       Date:  2011-11-09       Impact factor: 1.559

Review 2.  Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects.

Authors:  Wasin Charerntantanakul
Journal:  World J Virol       Date:  2012-02-12

3.  Safety and efficacy of a novel European vaccine for porcine reproductive and respiratory virus in bred gilts.

Authors:  Michael D Piontkowski; Jeremy Kroll; Francois-Xavier Orveillon; Christian Kraft; Teresa Coll
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

4.  Reproductive parameters following a PRRS outbreak where a whole-herd PRRS MLV vaccination strategy was instituted post-outbreak.

Authors:  Em-on Olanratmanee; Suparlark Nuntawan Na Ayudhya; Roongroje Thanawongnuwech; Annop Kunavongkrit; Padet Tummaruk
Journal:  Trop Anim Health Prod       Date:  2012-12-02       Impact factor: 1.559

5.  Reproductive performance of sows with and without PRRS modified live virus vaccination in PRRS-virus-seropositive herds.

Authors:  Em-On Olanratmanee; Roongroje Thanawongnuwech; Annop Kunavongkrit; Padet Tummaruk
Journal:  Trop Anim Health Prod       Date:  2014-05-10       Impact factor: 1.559

6.  Oral fluid samples used for PRRSV acclimatization program and sow performance monitoring in endemic PRRS-positive farms.

Authors:  Yonlayong Woonwong; Roongtham Kedkovid; Jirapat Arunorat; Chaitawat Sirisereewan; Teerawut Nedumpun; Korakrit Poonsuk; Yaowalak Panyasing; Pariwat Poolperm; Alongkot Boonsoongnern; Roongroje Thanawongnuwech
Journal:  Trop Anim Health Prod       Date:  2017-10-05       Impact factor: 1.559

7.  Porcine reproductive and respiratory syndrome virus detection in Thailand during 2005-2010 in relation to clinical problems, pig types, regions, and seasons.

Authors:  Padet Tummaruk; Pannin Surapat; Sutharat Sriariyakun; Oraphan Seemakram; Em-on Olanratmanee; Rachod Tantilertcharoen; Roongroj Thanawongnuwech
Journal:  Trop Anim Health Prod       Date:  2012-10-13       Impact factor: 1.559

8.  Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus.

Authors:  Hiep L X Vu; Byungjoon Kwon; Marcelo de Lima; Asit K Pattnaik; Fernando A Osorio
Journal:  Vaccine       Date:  2013-07-23       Impact factor: 3.641

9.  Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region.

Authors:  Julia Stadler; Lena Naderer; Lisa Beffort; Mathias Ritzmann; Daniela Emrich; Walter Hermanns; Kerstin Fiebig; Armin Saalmüller; Wilhelm Gerner; Bernadette Glatthaar-Saalmüller; Andrea Ladinig
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

10.  Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.

Authors:  Patricia Renson; Christelle Fablet; Mathieu Andraud; Valérie Normand; Arnaud Lebret; Frédéric Paboeuf; Nicolas Rose; Olivier Bourry
Journal:  Vaccine       Date:  2019-06-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.